Aug 27, 2026 09:01AM
Aug 14, 2026 08:30AM
Jul 31, 2026 10:12AM
Jul 31, 2026 10:12AM
Jul 31, 2026 08:10AM
Jul 31, 2026 08:10AM
Jul 6, 2026 08:33AM Moleculin CEO discusses early MIRACLE trial data in investor segment
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM
Jun 30, 2026 08:30AM
Jun 30, 2026 08:30AM
Jun 5, 2026 08:29AM
Jun 5, 2026 08:29AM
Jun 4, 2026 08:31AM Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
May 29, 2026 08:21AM
May 21, 2026 05:02PM
May 21, 2026 05:02PM
May 15, 2026 08:30AM
May 13, 2026 08:03AM
May 13, 2026 08:00AM
May 12, 2026 09:30AM Moleculin's Annamycin shows no significant heart toxicity in leukemia study
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 8, 2026 08:45AM
May 8, 2026 08:45AM
Apr 23, 2026 08:27AM
Apr 23, 2026 08:25AM
Apr 21, 2026 08:36AM Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting
Apr 7, 2026 12:52PM
Apr 7, 2026 08:42AM
Apr 7, 2026 08:36AM
Apr 7, 2026 08:36AM
Mar 23, 2026 08:33AM
Mar 23, 2026 08:31AM
Mar 23, 2026 08:31AM Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Mar 19, 2026 08:36AM
Mar 17, 2026 09:05AM
Mar 11, 2026 09:00AM
Mar 11, 2026 09:00AM
Feb 19, 2026 08:39AM
Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM Moleculin reports 40% response rate in leukemia drug trial
Feb 18, 2026 08:20AM
Feb 17, 2026 08:35AM
Feb 17, 2026 08:35AM
Feb 13, 2026 08:35AM
Feb 13, 2026 08:32AM
Feb 5, 2026 09:15AM
Jan 13, 2026 08:55AM Moleculin reports no cardiotoxicity in 90 Annamycin trial subjects
Jan 13, 2026 08:55AM

330,199 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All